Schizophrenia 25 Sep, 2019 Video #6: Which patients are best suited for long-acting injectable antipsychotics? Professor John Kane discusses the often-asked question, who is the ideal candidate for long-acting antipsychotic treatment? Sign up for Progress in Mind Middle East and Africa Sign up for our newsletter and stay updated on new content and resources. Related Article Article 3: Lessons from before and after COVID-19: Why Healthcare Should Never Be the Same Depression Article Prevention key to reducing suicide deaths Schizophrenia Article Improving long-term outcomes in schizophrenia — translating evidence into practice